Moderna (MRNA) is a publicly traded Healthcare sector company. As of August 19, 2026, MRNA trades at $62.98 with a market cap of $25.73B and a P/E ratio of -7.96. MRNA moved -2.37% today. Year to date, MRNA is +113.50%; over the trailing twelve months it is +124.14%. Its 52-week range spans $22.28 to $85.60. Analyst consensus is neutral with an average price target of $48.92. Rallies surfaces MRNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for MRNA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $62.98 |
| Market Cap | $25.73B |
| P/E Ratio | -7.96 |
| EPS | $-7.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $85.60 |
| 52-Week Low | $22.28 |
| Volume | 3.27M |
| Avg Volume | 0 |
| Revenue (TTM) | $2.23B |
| Net Income | $-3.15B |
| Gross Margin | 23.38% |
15 analysts cover MRNA: 0 strong buy, 1 buy, 12 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $48.92.